Literature DB >> 28285547

Objective physical activity measurement in people with multiple sclerosis: a review of the literature.

Blathin Casey1, Susan Coote1, Alan Donnelly2.   

Abstract

PURPOSE: The purpose of this study is to identify the objective physical activity (PA) measurement tools and outputs that are used within Multiple Sclerosis (MS) literature.
METHODS: A systematic search strategy on eight databases (2000-2016) using keywords associated with MS and PA.
RESULTS: This review includes 32 papers. Uni-axial accelerometers were the most popular objective PA tool in this review (68%). Pedometers (14%) and multi-sensor systems (3%) were the second and third most common. PA outputs included activity counts per day, steps per day, energy expenditure per day, minutes of moderate-vigorous PA (MVPA), minutes of light PA and daily dynamic activity. Both activity counts per day (n = 21 studies), and steps per day (n = 11 studies) were most commonly used representing 78%.
CONCLUSION: Uni-axial accelerometers and pedometers are the most popular PA measurement tools used in MS literature. However, developments in the field mean that most new sensors are tri-axial, and multi-sensor systems are also available. Researchers should use devices with published validation information, and should utilize the detail on activity patterns available from accelerometer measurement instead of expressing a single unit such as activity counts or step counts per day. Attention to capturing the duration, frequency, intensity and energy expended during daily PA is warranted. Implications for Rehabilitation The review reports that accelerometers were the research tool most frequently reported in the literature, though there were differences in device type and in how activity data was extracted from the stored information. The majority of research studies of physical activity levels in Multiple Sclerosis fail to provide an adequate range of activity outcomes, frequently using outcomes which do not allow simple cross-comparisons with other populations.

Entities:  

Keywords:  Physical activity; accelerometers; multiple sclerosis

Mesh:

Year:  2017        PMID: 28285547     DOI: 10.1080/17483107.2017.1297859

Source DB:  PubMed          Journal:  Disabil Rehabil Assist Technol        ISSN: 1748-3107


  7 in total

Review 1.  Performance Measures for Upper Extremity Functions in Persons with Multiple Sclerosis.

Authors:  Turhan Kahraman
Journal:  Noro Psikiyatr Ars       Date:  2018       Impact factor: 1.339

Review 2.  Performance and Capacity Measurement of the Lower Extremities in Multiple Sclerosis -How to Approach?

Authors:  Sıla Usar İncirli; Özlem Taşkapilioğlu
Journal:  Noro Psikiyatr Ars       Date:  2018       Impact factor: 1.339

Review 3.  The Role of Wearable Devices in Multiple Sclerosis.

Authors:  Maddalena Sparaco; Luigi Lavorgna; Renata Conforti; Gioacchino Tedeschi; Simona Bonavita
Journal:  Mult Scler Int       Date:  2018-10-10

4.  Three distinct physical behavior types in fatigued patients with multiple sclerosis.

Authors:  H E M Braakhuis; M A M Berger; G A van der Stok; J van Meeteren; V de Groot; H Beckerman; J B J Bussmann
Journal:  J Neuroeng Rehabil       Date:  2019-08-23       Impact factor: 4.262

5.  Using real-world accelerometry-derived diurnal patterns of physical activity to evaluate disability in multiple sclerosis.

Authors:  Jennifer L Keller; Fan Tian; Kathryn C Fitzgerald; Leah Mische; Jesse Ritter; M Gabriela Costello; Ellen M Mowry; Vadim Zippunikov; Kathleen M Zackowski
Journal:  J Rehabil Assist Technol Eng       Date:  2022-01-12

Review 6.  Wearables for Measuring the Physical Activity and Sedentary Behavior of Patients With Axial Spondyloarthritis: Systematic Review.

Authors:  Julie Soulard; Thomas Carlin; Johannes Knitza; Nicolas Vuillerme
Journal:  JMIR Mhealth Uhealth       Date:  2022-08-22       Impact factor: 4.947

Review 7.  The Role of Remote Monitoring in Evaluating Fatigue in Multiple Sclerosis: A Review.

Authors:  Valerie J Block; Riley Bove; Bardia Nourbakhsh
Journal:  Front Neurol       Date:  2022-06-27       Impact factor: 4.086

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.